Pelthos Therapeutics attended the LEADderm 2026 conference in Newport Beach.
Public source
Publisher name
Public post
Coming back from a great weekend at LEADderm 2026 in Newport Beach. Events like this are a great reminder of how much there is to learn from the people shaping the futur…
Company
Pelthos Therapeutics
Innovative therapies for patients with unmet needs.
- Industry
- Pharmaceutical Manufacturing
- Location
- Durham, US
- Company size
- 51–200 employees
About Pelthos Therapeutics
Pelthos Therapeutics is a biopharmaceutical company committed to commercializing innovative therapeutic products for high unmet patient needs. The company’s lead product is ZELSUVMI™ (berdazimer) topical gel, 10.3%, for the treatment of Molluscum contagiosum.
See moreLatest activity
Latest activity from Pelthos Therapeutics
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. is heading to Maui Derm NP+PA Fall at Booth 313 to meet the team and discuss advancing care through innovative solutions.
Presence & Recognition
AltaThera Pharmaceuticals
AltaThera Pharmaceuticals is attending the Midwest Pediatric Cardiology Society Annual Meeting in Pittsburgh next week.
Presence & Recognition
SERB Pharmaceuticals
SERB Pharmaceuticals is attending the ETA2026 event hosted by the European Thyroid Association to meet with physicians and members of the scientific community at Booth B20.
Presence & Recognition
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. is attending the ERS2026 event in Barcelona, one of the world's largest gatherings of clinicians, researchers, and healthcare professionals focused on respiratory medicine.
Presence & Recognition
Elusa Health